लोड हो रहा है...
Rationale and design of a phase III safety trial of idarucizumab in children receiving dabigatran etexilate for venous thromboembolism
ESSENTIALS: There is no data on the use of idarucizumab in children with venous thromboembolism (VTE). We present the design of a trial that will assess the safety of idarucizumab in children with VTE. Patients will be recruited from two ongoing trials in children treated with dabigatran for VTE. Id...
में बचाया:
| में प्रकाशित: | Res Pract Thromb Haemost |
|---|---|
| मुख्य लेखकों: | , , , , , , , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
John Wiley and Sons Inc.
2017
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5868044/ https://ncbi.nlm.nih.gov/pubmed/30046708 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/rth2.12053 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|